Clinical Trials of Antidepressants

ebook How Changing the Model Can Uncover New, More Effective Molecules · SpringerBriefs in Psychology

By Martin M. Katz

cover image of Clinical Trials of Antidepressants

Sign up to save your library

With an OverDrive account, you can save your favorite libraries for at-a-glance information about availability. Find out more about OverDrive accounts.

   Not today

Find this title in Libby, the library reading app by OverDrive.

Download Libby on the App Store Download Libby on Google Play

Search for a digital library with this title

Title found at these libraries:

Library Name Distance
Loading...

This brief guide takes current clinical trial protocols to task and replaces them with a contemporary framework for improving next-generation antidepressants and their underlying science. Innovative models are based on a nuanced, neurologically-informed understanding of drug mechanisms and the component cognitive, mood, and behavioral aspects of depression. The book reconceptualizes not only the clinical trial process but the clinical concept of depression itself as essential to bringing pharmaceutical research and development up to date, boosting efficiency and effectiveness, finding new molecules, and reducing waste. Case studies and a review of salient depression scales illustrate the potential benefits of such wide-scale change. 

Included in the coverage: 

Why now the need for a new clinical trials model for antidepressants?
  • Aims and basic requirements of clinical trials: conventional and component-specific models.
  • Methods for measuring the components and the profile of drug actions: the multivantaged approach.
  • Achieving the ideal clinical trial: an example of the merged componential and established models.
  • Prediction and shortening the clinical trial.
  • The video clinical trial. 
  • Clinical Trials of Antidepressants will interest a varied audience, including clinical investigators, academic and pharmaceutical company scientists, clinical trial organizations, psychiatrists, outpatient physicians, psychotherapists, clinical psychologists, psychology graduate students, medical students, and government agencies such as the FDA.

    Clinical Trials of Antidepressants